Irinotecan in Treating Children With Refractory Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial is studying irinotecan to see how well it works in treating children with
refractory solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells
from dividing so they stop growing or die.